1910 Genetics


1910 Genetics is a biotechnology company focused on advancing small and large molecule drug discovery using a multimodal AI platform integrated with laboratory automation. Their mission is to make undruggable targets a thing of the past, leveraging proprietary data streams and computational technologies to develop novel therapeutics across various disease areas. They collaborate with leading pharma and tech partners, and are backed by prestigious investors. The company emphasizes the integration of biology, AI, and computation to accelerate drug discovery and development.

Industries

artificial-intelligence
biotechnology
therapeutics

Nr. of Employees

small (1-50)

1910 Genetics

Boston, Massachusetts, United States, North America


Services

Software Development and AI/ML Solutions

Development of AI/ML models, cloud-based platforms, and software solutions to support drug discovery.

Laboratory Automation and Biotech Operations

Design and management of laboratory automation systems, lab operations, and biological assay automation.

Drug Discovery and Medicinal Chemistry

Research and development of small and large molecule therapeutics, including hit identification, lead optimization, and candidate nomination.

Business Development and Strategic Partnerships

Identifying and executing strategic collaborations, licensing, and partnership deals.

Research and Scientific Innovation

Cutting-edge research in AI, computation, biology, and chemistry to support drug discovery.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.